Viatris Inc. (VTRS) is listed on NASDAQ in Pharmaceutical Stocks. It is $16.34, -3.26%, with a $18.8B market cap. RSI is 45.3, neutral. The latest reported quarter beat estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 45.3 Neutral
Market Cap $18.8B
Volume 5.2M
Fundamentals — 10-Q Q2 2026
Revenue $7.3B
Net Income --
EPS $0.05
Gross Margin 35.9%
Operating Margin -1.0%
Debt / Equity 0.8x
P/E Ratio 326.8x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Campbell Paul | Insider | Sell | 50,076 | $16.17 | $809,784 | 2026 Jun 25 |
| Campbell Paul | Insider | Sell | 21,350 | $13.28 | $283,539 | 2026 Mar 23 |
| Le Goff Corinne | Chief Commercial Officer | Sell | 7,032 | $10.25 | $72,078 | 2025 Sep 11 |
| Smith Scott Andrew | Chief Executive Officer | Buy | 22,000 | $9.99 | $219,780 | 2025 Aug 12 |
| Smith Scott Andrew | Chief Executive Officer | Buy | 60,000 | $8.94 | $536,400 | 2025 May 12 |
| Campbell Paul | Officer | Sell | 26,925 | $12.88 | $346,794 | 2024 Nov 11 |
| Malik Rajiv | Director | Sell | 200,000 | $11.68 | $2.3M | 2024 Sep 12 |
| Malik Rajiv | Director | Sell | 100,000 | $11.95 | $1.2M | 2024 Aug 30 |
| Malik Rajiv | Director | Sell | 300,000 | $11.74 | $3.5M | 2024 Aug 23 |
| Malik Rajiv | Director | Sell | 349,960 | $10.26 | $3.6M | 2024 Jun 14 |
| Roman Brian | Chief Legal Officer | Sell | 89,419 | $10.38 | $928,169 | 2024 May 28 |
| Mauro Anthony | Officer | Sell | 250,000 | $12.09 | $3.0M | 2024 Mar 13 |
| Campbell Paul | Officer | Sell | 24,353 | $12.33 | $300,272 | 2024 Mar 5 |
| Lyons Dillon JoEllen | Director | Sell | 20,000 | $12.36 | $247,200 | 2024 Mar 5 |
| Ni Xiangyang (Sean) | President, Greater China | Sell | 21,532 | $12.51 | $269,331 | 2024 Mar 4 |
| Cuneo Andrew | Officer | Sell | 4,000 | $13.50 | $54,000 | 2024 Feb 23 |
| Cuneo Andrew | Officer | Sell | 4,000 | $12.50 | $50,000 | 2024 Feb 15 |
| Cuneo Andrew | Officer | Sell | 4,000 | $11.50 | $46,000 | 2024 Jan 4 |
| Cuneo Andrew | Officer | Sell | 4,000 | $10.50 | $42,000 | 2023 Dec 14 |
| Ni Xiangyang (Sean) | President, Greater China | Sell | 14,937 | $9.37 | $139,960 | 2023 Nov 24 |
Other Pharmaceutical Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $1,173.34 | 46.3 | $1.1T |
| | $268.01 | 58.6 | $645.9B |
| | $148.31 | 64.1 | $365.9B |
| | $90.36 | 35.0 | $8.0B |
| | $44.82 | 51.9 | -- |
| | $199.01 | 34.8 | $10.4B |
| | $47.41 | 37.2 | $8.0B |
Take VTRS further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put VTRS in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Viatris Inc. next reports.
Set alerts on VTRS
Get notified when Viatris Inc. hits your price targets or technical conditions are met.
Get Started Free